CXCR4 and CXCL12 in Kidney Cancer
Author Information
Author(s): Schrader A J, Lechner O, Templin M, Dittmar K E J, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T, Gatzlaff P, Atzpodien J, Buer J, Lauber J
Primary Institution: German Research Centre for Biotechnology (GBF)
Hypothesis
The study investigates the expression and function of CXCL12α/CXCR4 in kidney cancer.
Conclusion
The study found that CXCR4 is upregulated in kidney cancer tissues while CXCL12α is downregulated, suggesting a potential role in tumor progression.
Supporting Evidence
- CXCR4 was found to be significantly upregulated in malignant kidney tissue compared to normal tissue.
- CXCL12α expression was significantly lower in kidney cancer samples than in adjacent normal tissue.
- Functional CXCR4 receptors were detected on the surface of A-498 kidney cancer cells.
Takeaway
This study looked at how two proteins, CXCR4 and CXCL12, behave in kidney cancer, finding that one is more active in tumors while the other is less active.
Methodology
The study analyzed CXCL12α/CXCR4 expression in kidney cancer cell lines and patient samples using RT-PCR and cDNA expression arrays.
Potential Biases
Potential bias in sample selection and the specific focus on clear cell type RCC.
Limitations
The study is limited to a small sample size and specific cancer cell lines.
Participant Demographics
Patients with renal cell carcinoma of the clear cell type.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website